Osmotica Pharmaceuticals plc (OSMT), which recently made its debut on the Nasdaq, is down 12% since its IPO while the iShares Nasdaq Biotechnology ETF (IBB) index has lost nearly 5% of its value for the same period.
from RTT - Biotech https://ift.tt/2AJPzch
via IFTTT
No comments:
Post a Comment